Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00021736
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2001-08-03
Brief Title:
Phase IIIII Study of Anti-VEGF in Neovascular AMD
Sponsor:
Eyetech Pharmaceuticals
Organization:
Eyetech Pharmaceuticals
Organization Data
Organization:
Eyetech Pharmaceuticals
Class:
INDUSTRY
Study ID:
EOP1004B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eyetech Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None